- Upstream Ag Insights
- Posts
- Upstream Ag Professional - December 7th 2025
Upstream Ag Professional - December 7th 2025
Essential news and analysis for agribusiness leaders.
Welcome to the 122nd edition of Upstream Ag Professional
Index
Mapping Power in the Seed Value Chain: Who Wins, Who Loses, and Why
2025 Crop Life 100 Report: Highlights and Analysis
Harvest Loss Technology
New Partnership Unites Bushel Plus SmartPan™ System with John Deere Harvest Settings Automation Technology
Farmwave Patent
Provivi, Syngenta strike major Brazil deal on pheromone pest control
Trump administration backs Bayer's bid to curb Roundup lawsuits
FMC at Goldman Sachs Industrials and Materials Conference 2025
The Last Human Edge
Other Interesting Ag Articles (8 this week)
Thank you for being an Upstream Ag Professional member!
This week’s audio edition can be found here and covers the following:
Provivi, Syngenta strike major Brazil deal on pheromone pest control
FMC at Goldman Sachs Industrials and Materials Conference 2025
Harvest Loss Technology
2025 Crop Life 100 Report: Highlights and Analysis
1. Mapping Power in the Seed Value Chain: Who Wins, Who Loses, and Why - Upstream Ag Professional
Introduction
Cornered Resources
Germplasm
The Seed Value Chain
Commoditize the Complement
Gene Editing Company Hurdles
Monsanto vs. Pioneer
Potential Avenues for Value Shifts?
Final Thoughts

Last month, I wrote about The Four Forces Reshaping the Crop Protection Industry, and the month before that I wrote about the The Danger of Dominant Logic and Pioneer’s Blind Spot.
It’s interesting to bring that together with a question to the Corteva executive team on their recent earnings call from an analyst:
If we look, say, 15 years down the road in seeds, given the lower barriers to entry created by gene editing, is it possible that the seed company business model evolves to look more like a CPG company such as L’Oréal or Pepsi — essentially an acquirer and marketer of smaller technology brands? And how do you think about that in the context of R&D and budgeting?
The question to me represents an opportunity to unpack the components of the seed industry and how that impacts where competitive advantage comes from in the segment.
Cornered Resources
One of the most renowned books on strategy is Hamilton Helmers 7 Powers.
Helmer’s framework boils strategy down to a single core outcome: durable returns.
The book suggests that strategy is about identifying and building structural advantages that competitors can’t easily replicate, leading to better returns. Helmer calls this “power.”
He defines power as any mechanism that sustainably raises a firm’s long-term profitability, then categorizes the landscape into seven forms:
scale economies
network economies
counter-positioning
switching costs
branding
cornered resource, and
process power
Seed companies can likely cite several areas within those seven that give them a competitive advantage, but I want to focus on one: cornered resource.
A cornered resource is an asset that others can’t access on comparable terms and that exclusivity translates into strategic advantage. It can be a proprietary technology, a long-term licensing agreement, unique data, or anything structurally difficult to acquire or substitute. That means, competitors can see the value but can’t replicate the resource at any reasonable cost.
Germplasm
Elite germplasm is a cornered resource in the seed world. Gene editing companies usually do not have access to it, at least not high quality germplasm.
Germplasm is the genetic base of seeds, breeding lines, and genomic libraries. It is the foundation behind every crop variety. Its value compounds over time because improvement is cumulative and path dependent, shaped by decades of breeding decisions, field trials, and data integration. Elite corn germplasm, for example, doesn’t materialize over night, it emerges from crossing inbred lines, evaluating hybrids across environments, and continuously refining traits like yield, standability, and stress tolerance. This process compounds over generations.
Pioneer Hi-Bred, now part of Corteva (and soon to be stand alone again), has been at it since 1926, building a library of corn genetics that companies cannot readily recreate, especially in a traditional venture cycle.
We see this reinforced with the consolidation in the seed industry, particularly in the 90’s and early 2000’s. Companies actively acquiring disparate lines and companies to not only build out germplasm, but distribution:
For the full break down check out the link in the heading.
Related: The Billion-Dollar Problem Big Ag Ignores - SFTW
2. 2025 Crop Life 100 Report - Crop Life

Highlights

Subscribe to Upstream Ag Professional to read the rest.
Become a paying member of Upstream Ag to get access to this post and other subscriber-only content.
Already a paying subscriber? Sign In.
A Professional Membership Delivers:
- • Subscriber-only insights and deep analysis plus full archive access
- • Audio edition for consumption flexibility
- • AskUpstream Access, the LLM for serious agribusiness professionals
- • Access to the Report Hub and Visualization Hub
